Rationalizing Use of Pembrolizumab/Bevacizumab in Recurrent Ovarian Cancer Targeted Oncology 1:00 5 years ago 408 Далее Скачать
Final ANANOVA2 Survival Data Support Niraparib Plus Bevacizumab in Recurrent Ovarian Cancer Targeted Oncology 1:42 4 years ago 174 Далее Скачать
Dose-Dense Chemotherapy for Ovarian Cancer; Adding Bevacizumab OncLive 6:20 7 years ago 832 Далее Скачать
AGO-OVAR 2.29/ENGOT-ov34: atezolizumab vs placebo + bevacizumab w/ chemo recurrent ovarian cancer VJOncology 6:10 7 months ago 97 Далее Скачать
Dr. Mirza on Efficacy of Niraparib/Bevacizumab Combo in Recurrent Ovarian Cancer OncLive 2:18 5 years ago 300 Далее Скачать
Dr. Essel Discusses Long-Term Bevacizumab in Ovarian Cancer OncLive 1:05 6 years ago 158 Далее Скачать
Results of Niraparib/Bevacizumab Combo in Platinum-Sensitive Recurrent Ovarian Cancer Targeted Oncology 2:25 5 years ago 301 Далее Скачать
Considerations for Managing Recurrent Ovarian Cancer Targeted Oncology 5:31 4 years ago 159 Далее Скачать
Ovarian Cancer Subtypes May Predict Response to Bevacizumab Mayo Clinic 1:59 10 years ago 900 Далее Скачать
Strategies for Managing Recurrent Ovarian Cancer SHARE Cancer Support 1:00:19 4 years ago 1 192 Далее Скачать
Dr. Tew Evaluates Bevacizumab Treatment in Ovarian Cancer OncLive 1:36 13 years ago 1 665 Далее Скачать
